In the first quarter, the company experienced a 9.8% growth in same-store net revenue and an impressive 60% increase in adjusted EBITDA to $495 million. Excluding pandemic relief funds, adjusted EBITDA still grew by 6% compared to the first quarter of 2019, highlighting the underlying strength of the core portfolio. The company's expense management initiatives remain effective, with progress made during the quarter. Despite challenges from COVID surges and weather disruptions, March volumes rebounded significantly, closing the gap with pre-pandemic levels. The implementation of strategic initiatives, such as new hospital openings, expansion of service lines, and investment in outpatient access, is expected to drive long-term growth. The company remains focused on improving adjusted EBITDA margins, reducing leverage, and generating positive annual free cash flow in the medium term.